Sichenzia Ross Ference LLP represented EzFill Holdings in the offering. EzFill Holdings, Inc. (NASDAQ: “EZFL”), a pioneer in the mobile fuel industry, announced a $2,096,000 At-The-Market...
EzFill’s $2 Million At-The-Market Offering
The NFT Gaming Company’s $7 Million Initial Public Offering
Sheppard, Mullin, Richter & Hampton advised the NFT Gaming Company, while Sichenzia Ross Ference LLP represented Laidlaw & Company (UK) Ltd. in the offering. The NFT...
Bullfrog AI Holdings’ $8.4 Million Initial Public Offering
Sichenzia Ross Ference represented Bullfrog AI Holdings, Inc. in the offering, while Carmel, Milazzo & Feil represented the underwriters. Bullfrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW),...
Alset’s $3.8 Million Common Stock Offering
Sichenzia Ross Ference and Jones, Davis & Jackson represented Alset Inc. in the offering, while Kaufman & Canoles represented Aegis Capital Corp. Alset Inc. (NASDAQ: AEI),...
Genetic Technologies’ $5 Million American Depositary Shares Offering
Sichenzia Ross Ference represented Genetic Technologies Limited in the offering. Ellenoff Grossman & Schole represented the placement agent. Genetic Technologies Limited (ASX:GTG, NASDAQ: GENE), a global...
Sharps Technology’s $3.8 Million At-the-Market Private Placement
Sichenzia Ross Ference represented Sharps Technology in the transaction. Sharps Technology, Inc. (Nasdaq: STSS and STSSW) (the “Company”), an innovative medical device company offering patented, best-in-class,...
BiondVax Pharmaceuticals’ $8 Million Public Offering
Sichenzia Ross Ference represented Aegis Capital Corp. as sole book running manager in the offering. BiondVax Pharmaceuticals executed the $8 Million underwritten public offering. The offering consisted...
Silo Pharma’s $5.75 Million Public Offering and Nasdaq Uplisting
Sichenzia Ross Ference represented Laidlaw & Company (UK) Ltd. în the transaction while Sheppard Mullin advised Silo Pharma. Silo Pharma, Inc. (Nasdaq: SILO) announced the $5.75 million...
Amesite’s $2.3 Million Direct Offering and Private Placement
Sichenzia Ross Ference LLP represented Laidlaw & Company on the deal while Sheppard Mullin advised Amesite. Amesite Inc announced a registered direct offering of 4,181,821 shares of...
Relmada Therapeutics’ $100 Million At-The-Market Offering
Sichenzia Ross Ference represented Relmada Therapeutics in the transaction. Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, executed a $100 million At-The-Market offering facility (“ATM”)....
Tantech Holdings’ $10 Million Shares Offering
Sichenzia Ross Ference represented Aegis Capital Corp. as sole book runner in the offering. Tantech Holdings Ltd (NASDAQ: TANH) executed its offering which included 20,000,000 shares of...
Alset Capital Acquisitions Corp.’s $86.25 Million Initial Public Offering
Sichenzia Ross Ference represented Alset Capital Acquisition Corp. on the transaction. Ortoli Rosenstadt LLP acted for EF Hutton. Alset Capital Acquisition Corp. (Nasdaq: ACAXU), a newly...